CellMark Biopharma, the leading biotech company 'Fueling the Fight Against Cancer', today announced that Craig A. Pisaris-Henderson joined CellMark Biopharma as the company's Chief Operating Officer and Board Member.
"Craig has been a key team member and trusted advisor as we've been building the foundation of [CellMark](http://www.cellmarkbiopharma.com/about-us/management/) over the past year," stated Derek Vest, founder and CEO of CellMark Biopharma. "Craig's extensive experience in building and expanding global companies and his expertise in the technology sector make him a perfect fit for CellMark as we integrate cutting edge medicine with cutting edge technological processes."
As COO, Mr. Pisaris-Henderson will oversee day-to-day non-medical operations including marketing and corporate finances. "I'm elated to be a part of such a noble mission in providing solutions for those afflicted with such a terrible disease as cancer," stated Mr. Pisaris-Henderson. "Being able to leverage the past two decades of creating pioneering products and services within the tech sector in a manner that will help millions of people around the world provides an incredible feeling and purpose to ones life - I'm truly humbled to be working with such an extraordinary team at CellMark."
Through the past 25 years Mr. Pisaris-Henderson has been immersed in the digital and data analytic sector with an emphasis on leveraging 'big data' in the development of predictive business processes and marketing strategies for private and public entities. Most recently, Mr. Pisaris-Henderson founded Lexos Media, a pioneering digital ad servicing technology maintaining the largest patent portfolio related to cursor, touch, and eye-gaze integration (analytics) with online digital advertising.
Prior to Lexos, Mr. Pisaris-Henderson was the Founder / CEO / Chairman of MIVA, Inc. (NASDAQ: MIVA f/k/a FindWhat.com NASDAQ: FWHT). Mr. Pisaris-Henderson lead FindWhat.com/MIVA, a global leader in analytically driven performance-based marketing and commerce enabling services, to global sales in excess of $225M, a NASDAQ market valuation approaching $1B, and over 500 team members with office in the U.S., Japan, UK, and throughout the EU.
Mr. Pisaris-Henderson has been a featured speaker at numerous investment banking and industry conferences, is the recipient of the Ernst & Young's Entrepreneur of the Year Award, received an hPHD in Business Administration, and been awarded many other national and regional distinctions. Mr. Pisaris-Henderson has served as a board member for Florida Gulf Coast University's College of Business, Lexos Media and several other private and public companies.
INDUSTRY KEYWORDS: Biotechnology, Biotech, Cancer, cachexia, chemo brain, chemo fog, Derek Vest, Craig Pisaris-Henderson, Erica Boliek, cancer super drink, Clinical Trials, Oncology, CellMark Biopharma, CellAssure, Cognify Kalos Therapeutics, Dr. Stan Headley, Daniel Von Hoff, Stand Up To Cancer, Pharmaceutical, Research, Health, malnutrition, medical nutrition, Palliative Care
